http://dx.doi.org/10.1177/0269881109105137
pubmed: 19423613
scopus: 77950449612
Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients
April 2010
Article
| Related Files |
|---|
|
Redirect to Publisher's version
(Publisher's version.url.txt, 42 bytes) |
Abstract: The present study investigated the influence of gender and menopausal status on treatment response in depressed inpatients, treated with either imipramine or fluvoxamine. The patients were divided into three groups: men, premenopausal women and postmenopausal women. A multivariate analysis was performed using the difference in Hamilton score (pretreatment - post-treatment) for imipramine and fluvoxamine as dependent variable. The following independent variables were used: the baseline Hamilton score, the antidepressant used, the gender-group and the interaction between the type of antidepressant and gender. In total, 138 patients with a DSM IV diagnosis of depressive disorder were analysed. Men responded more favorably to imipramine (B = 7.12, P = 0.005). Premenopausal women had a better response rate to fluvoxamine than men (B = -8.66, P = 0.027). In depressed inpatients, men respond more favorably to imipramine than to fluvoxamine. Premenopausal women respond more frequently to fluvoxamine than men.
- Male
- Adult
- Aged
- Female
- Humans
- Questionnaires
- Middle Aged
- Treatment Outcome
- Netherlands
- Sex Factors
- Young Adult
- Single-Blind Method
- Linear Models
- Double-Blind Method
- Psychiatric Status Rating Scales
- *Inpatients
- Fluvoxamine/*therapeutic use
- Imipramine/*therapeutic use
- Antidepressive Agents/*therapeutic use
- Menopause/*psychology
- Depressive Disorder/diagnosis/*drug therapy/psychology